Should we start screening programmes in Europe?

Lunchtime session
Chairs: Georgia Hardavella (London, United Kingdom), Sam Janes (London, United Kingdom)
Aims: To present the latest data concerning our capacity to early diagnose cancers; discuss and explain apparently divergent results from different trials;) describe the possible harms that relate to the screening and diagnosis process; and detail the different approaches with imaging modalities.
Target audience: Clinicians, Surgeons, Radiation Oncologists, Epidemiologist, General practitioners, Nurses

Two dimensional versus three dimensional analysis of nodules detected during screening Martine Remy-Jardin (Lille, France)
How to deal with the detected nodule ? David Baldwin (Nottingham, United Kingdom)